PERSPECTA

News from every angle

Back to headlines

Norway Approves Carvykti Cancer Treatment

Norway's Decision Forum has approved the introduction of Carvykti, a one-time cancer medicine offering up to eight years of improved quality of life for bone marrow cancer patients.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.